Presence of viral DNA in tissues of vulvar cancer patients

Nerodo G.A., Zykova T.A., Ivanova V.A., Nerodo E.A.

Rostov Research Institute of Oncology, Rostov-on-Don, Russia
Objective. Study of the presence of viral DNA in tissues of patients with vulvar cancer. Subject and methods. DNAs of HPV of high and low cancer risks and herpes viruses (HSV-1,2, cytomegalovirus, Epstein-Barr virus and human herpesvirus-6) were determined retrospectively in tumor tissue blocks from 148 vulvar cancer patients aged 14-85 years. Amplification with subsequent DNA detection was performed by Real-Time PCR with hybridization-fluorescent detection. Results. Infection with all virus types was detected in 47.3% of patients with vulvar cancer, including DNAs of HPV of different genotypes in 35.1%. Besides, we observed EBV (16.2%), human herpesvirus-6 (8.1%) and CMV (2.7%). The analysis of the dependence of the viral DNA presence on the disease stage demonstrated that viral DNAs were observed more frequently at early stages (stage I – 58.8%, stage II – 47.5% and stage III – 35.3%); HPV DNAs followed that pattern (stage I – 47.1%, stage II – 30% and stage III – 11.8%; p<0.01). Viral DNAs were detected in 75% of young patients and in 34% of old patients; HPV DNAs were found in 54.2% of young patients and in 18% of old patients, with HPV-16 predominance in both groups. Conclusion. The results confirmed the data on the existence of two pathogenetic variants of the development of vulvar cancer.

Keywords

vulvar cancer
HPV DNA
herpes viruses

Supplementary Materials

  1. Table 1. Spectrum of detection of viruses in patients with vulvar cancer in each stage of the disease, abs. h (%)
  2. Table 2. Detection of HPV DNA in patients with vulvar cancer, depending on the stage and age
  3. Table 3. Frequency of detection of genotypes of the HPV virus in patients with vulvar cancer, depending on the stage of the disease, abs. h (%)
  4. Table 4. The frequency of genotypes of the HPV virus in patients with vulvar cancer, depending on age, abs. h (%)

References

1. Неродо Е.А., Неродо Г.А., Иванова В.А. Анализ сроков появления рецидивов и безрецидивной выживаемости у больных раком вульвы. Российский медицинский журнал. 2014; 2: 18-21. [Nerodo E.A., Nerodo G.A., Ivanova V.A. The analysis of terms of onset of recurrences and survival without recurrences of patients with cancer of vulva. Rossiiskii meditsinskii zhurnal. 2014; 2: 18-21. (in Russian)]

2. Неродо Г.А., Непомнящая Е.М., Неродо Е.А. Клиническое течение рака вульвы у больных репродуктивного возраста. Креативная хирургия и онкология. 2012: 3: 61-6. [Nerodo G.A., Nepomnyashchaya E.M., Nerodo Е.A. Clinical course of vulvar cancer in reproductive patients. Kreativnaya khirurgiya i onkologiya. 2012: 3: 61-6. (in Russian)]

3. Ван дер Зее А. Современное лечение рака вульвы. Практическая онкология. 2009; 10(2): 84-5. [Van der Zee A. Modern treatment of vulvar cancer. Prakticheskaya onkologiya. 2009; 10(2): 84-5. (in Russian)]

4. Черенков В.Г., Петров А.Б., Александрова И.В., Егорова Е.С. Рак вульвы: современные методы диагностики и хирургического лечения. Вопросы онкологии. 2016. 62(4): 508-12. [Cherenkov V.G., Petrov A.B., Aleksandrova I.V., Egorova E.S. Cancer of the vulva: modern methods of diagnostics and surgical treatment. Voprosy onkologii. 2016. 62(4): 508-12. (in Russian)]

5. Ашрафян Л.А., Харченко Н.В., Киселев В.И., Свешников П.Г., Степанова Е.В., Бабаева Н.А. Рак вульвы: этиопатогенетическая концепция. М.: Молодая гвардия; 2006. 192с. [Ashrafyan L.A., Kharchenko N.V., Kiselev V.I., Sveshnikov P.G., Stepanova E.V., Babaeva N.A. Cancer of the vulva: etiopathogenetic concept. Moscow: Molodaya gvardiya; 2006. 192p. (in Russian)]

6. Вишневская Е.Е. Рак вульвы (по материалам РНПЦ ОМР им. Н.Н. Александрова). Онкологический журнал. 2008; 2(3): 38-42. [Vishnevskaya E.E. Cancer of the vulva (by materials of RNPTs OMR im. N.N. Aleksandrova). Onkologicheskii zhurnal. 2008; 2(3): 38-42. (in Russian)]

7. Вергейчик Г.И., Стрибук Ж.А., Еремин В.Ф., Шелкович С.Е., Дуда В.И. Значение вирусов папилломы человека высокого и низкого онкогенного риска в развитии генитальных папиллом, дисплазии и рака вульвы. Проблемы здоровья и экологии. 2010; 1(Прил. 1): 12-4. [Vergeichik G.I., Stribuk Zh.A., Eremin V.F., Shelkovich S.E., Duda V.I. Essential role of human papillomavirus on high and low oncogenic risk in the development of genital papillomas, dysplasia and cancer of vulva. Problemy zdorov’ya i ekologii. 2010; 1(suppl. 1): 12-4. (in Russian)]

8. Вергейчик Г.И. Папилломавирусная инфекция наружных половых органов. Новые подходы к диагностике и лечению. Сибирский онкологический журнал. 2012; 5: 18-22. [Vergeichik G.I. Papillomavirus infection of external genitals: new approaches to diagnosis and treatment. Sibirskii onkologicheskii zhurnal. 2012; 5: 18-22. (in Russian)]

9. Муршудова С.Х., Чулкова О.В., Филоненко Е.В. Классификация, этиология, патогенез и диагностика предрака и начального рака вульвы. Онкология. Журнал им. П.А. Герцена. 2013; 1: 63-7. [Murshudova S.Kh., Chulkova O.V., Filonenko E.V. Precancer and early cancer of the vulva: Classification, etiology, pathogenesis, and diagnosis. Onkologiya. Zhurnal im. P.A. Gertsena. 2013; 1: 63-7. (in Russian)]

10. Ueda Y., Enomoto T., Kimura T., Yoshino K., Fujita M., Kimura T. Two distinct pathways to development of squamous cell carcinoma of the vulva. J. Skin Cancer. 2011; 2011: 951250. doi: 10.1155/2011/951250.

11. Ordi J., Alejo M., Fuste V., Lloveras B., Del Pino M., Alonso I., Torne A. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. Am. J. Surg. Pathol. 2009; 33(11): 1659-65. doi: 10.1097/PAS.0b013e3181b40081.

12. Пушкарев В.А., Мазитов И.М. Рак вульвы. Медицинский вестник Башкортостана. 2013; 8(1): 123-32. [Pushkarev V.A., Mazitov I.M. Vulva cancer. Meditsinskii vestnik Bashkortostana. 2013; 8(1): 123-132. (in Russian)]

13. Ашрафян Л.А., Бабаева Н.А., Антонова И.Б., Ивашина С.В., Моцкобили Т.А., Алешикова О.И., Кузнецов И.Н. Папилломавирусная инфекция и нарушение баланса эстрогенных метаболитов как факторы риска развития рака органов женской репродуктивной системы. Онкология. Журнал им. П.А. Герцена. 2015; 4(1): 5-12. [Ashrafian L.A., Babaeva N.A., Antonova I.B., Ivashina S.V., Motskobili T.A., Aleshikova O.I. et al. Papillomavirus infection and estrogen metabolite imbalance as risk factors for cancer of the female reproductive system. Onkologiya. Zhurnal im. P.A. Gertsena. 2015; 4(1): 5-12. (in Russian)]

14. Айвазова Д.С., Пальчик Е.А., Хурасева А.Б. Вирусные инфекции в развитии неопластических поражение вульвы и влагалища в перименопаузальном периоде. Ученые записки Орловского государственного университета. 2015; 4: 269-272. [Aivazova D.S., Palchik E.A., Huraseva A.B. Viral infections in the development of neoplastic lesions of the vulva and vagina in the perimenopausal period. Uchenye zapiski Orlovskogo gosudarstvennogo universiteta. 2015; 4: 269-72. (in Russian)]

15. Ашрафян Л.А., Антонова И.Б., Басова И.О., Бабаева Н.А., Ивашина С.В. Рак вульвы, эндометрия, яичников в постменопаузе: роль инфекционного фактора. Опухоли женской репродуктивной системы. 2007; 4: 72-8. [Ashrafyan L.A., Antonova I.B., Basova I.O., Babayeva N.A., Ivashina S.V. Cancer of the vulva, endometrium, ovaries in postmenopause: implication of an infectious agent. Opukholi zhenskoi reproduktivnoi sistemy. 2007; 4: 72-78. (in Russain)]

16. Zykova T.A., Kit O.I., Nerodo G.A., Ivanova V.A., Nikitina V.P., Verenikina E.V., Kravtsova O.E., Bogomolova O.A. On Bacteroides Fragilis participation in vulvar carcinogenesis. J. Clin. Oncol. 2017; 35 (Suppl.): abstr e17026.

17. Van de Nieuwenhof H.P., van Kempen L.C., de Hullu J.A., Bekkers R.L., Bulten J., Melchers W.J. et al. The etiologic role of HPV in squamous cell carcinoma fine tuned. Cancer Epidemiol Biomarkers Prev. 2009; 18(7): 2061-7. doi: 10.1158/1055-9965.EPI-09-0209.

18. Nerodo G., Zykova T., Ivanova V., Nerodo E., Bogomolova O., Vladimirova L. Determination of viral DNA in patients with vulvar cancer in dependence on the presence of disease recurrence. Eur. J. Cancer. 2015; 51(Suppl. 3): S534-5.

19. Nerodo G.A., Kit O.I., Zykova T.A., Ivanova V.A., Nerodo E.A., Bogomolova O.A. HPV in tumor tissue, perifocal area and healthy tissue of patients with vulvar cancer. J. Clin. Oncol. 2016; 34(Suppl.): abstr. e17025.

20. Неродо Г.А., Зыкова Т.А., Иванова В.А., Неродо Г.А., Богомолова О.А. Инфицирование ВПЧ и герпес-вирусами опухолевой ткани у больных раком вульвы. Злокачественные опухоли. 2015; 4(Cпецвыпуск 2): 134-5. [Nerodo G.A., Zykova T.A., Ivanova V.A., Nerodo G.A., Bogomolova O.A. Infection with HPV and herpes viruses of tumor tissue in patients with vulvar cancer. Zlokachestvennye opukholi. 2015; 4(Suppl. 2): 134-35. (in Russain)]

21. Неродо Г.А., Зыкова Т.А., Неродо Е.А., Иванова В.А., Богомолова О.А. Частота инфицирования ткани опухоли вульвы вирусами папилломы человека и вирусами семейства герпеса. Молекулярная диагностика. 2014; 2(8): 75-6. [Nerodo G.A., Zykova T.A., Nerodo E.A., Ivanova V.A., Bogomolova O.A. The incidence of infection of the vulvar tumor tissue with human papillomaviruses and herpes viruses. Molekulyarnaya diagnostika. 2014; 2(8): 75-6. (in Russian)]

22. Урманчеева А.Ф., Тюляндин С.А., Моисеенко В.М. Практическая онкогинекология: избранные лекции. СПб.: Центр ТОММ; 2008. 400с. [Urmancheeva A.F., Tyulyandin S.A., Moiseenko V.M. Practical oncogynecology: selected lectures. St. Petersburg: Tsentr TOMM; 2008. 400p. (in Russian)]

23. Черенков В.Г., Александрова И.В., Шпенкова А.А. Рак вульвы: патогенетические варианты, диагностика, лечение, пластические операции. Опухоли женской репродуктивной системы. 2010; 4: 78-83. [Cherenkov V.G., Aleksandrova I.V., Shpenkova A.A. Vulvar cancer: pathogenetic types, diagnosis, treatment, plastic operations. Opukholi zhenskoi reproduktivnoi sistemy. 2010; 4: 78-83. (in Russian)]

24. Sznurkowski J.J., Zawrocki A., Emerich J. Рак вульвы: современные подходы к лечению. Медицинские аспекты здоровья женщины. 2011; 5: 65-70. [Sznurkowski J.J., Zawrocki A., Emerich J. Cancer of the vulva: modern approaches to treatment. Meditsinskie aspekty zdorov’ya zhenshchiny. 2011; 5: 65-70. (in Russian)]

Received 07.06.2017

Accepted 23.06.2017

About the Authors

Nerodo Galina Andreevna, MD, PhD, Professor, corresponding member of RAS, chief researcher at Rostov Research Institute of Oncology.
344037, Russia, Rostov-on-Don, 14-ya liniya 63. Tel.: +78633000200. E-mail: rnioi@list.ru
Zykova Tatiana Alekseevna, MD, PhD, Head of Laboratory of Virusology, Rostov Research Institute of Oncology.
344037, Russia, Rostov-on-Don, 14-ya liniya 63. Tel.: +78633000200. E-mail: rnioi@list.ru
Ivanova Viktoria Aleksandrovna, MD, PhD, Professor, oncologist at Rostov Research Institute of Oncology.
344037, Russia, Rostov-on-Don, 14-ya liniya 63. Tel.: +78633000200. E-mail: rnioi@list.ru
Nerodo Ekaterina Alekseevna, MD, PhD, oncologist at Consultative-diagnostic polyclinic No.121.
117042, Russia, Moscow, Yuzhnobutovskaya str. 87. Tel.: +74952568909. E-mail: rnioi@list.ru

For citations: Nerodo G.A., Zykova T.A., Ivanova V.A., Nerodo E.A. Presence of viral DNA in tissues of vulvar cancer patients. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (12): 89-95. (in Russian)
https://dx.doi.org/10.18565/aig.2017.12.89-95

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.